Pienta Kenneth 4
4 · Cue Biopharma, Inc. · Filed Feb 12, 2021
Insider Transaction Report
Form 4
Pienta Kenneth
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-10+50,000→ 50,000 totalExercise: $15.55Exp: 2031-02-09→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 10, 2021.